pylori IgG status and anti-CagA IgG status have higher risk of developing sarcopenia and low muscle mass (determined by SMI), whereas the other two indications of sarcopenia (i.e., low muscle strength and low physical performance) didn't show significant relationship. Here, S100A8 is linked to sarcopenia.